Structure of the human glucagon class B G-protein-coupled receptor

Nature

Volumn 499, Issue 7459, 2013, Pages 444-449

  Siu, Fai Yiu ^a   He, Min ^b   De Graaf, Chris ^c   Han, Gye Won ^a   Yang, Dehua ^b   Zhang, Zhiyun ^b   Zhou, Caihong ^b   Xu, Qingping ^d   Wacker, Daniel ^a   Joseph, Jeremiah S ^a   Liu, Wei ^a   Lau, Jesper ^e   Cherezov, Vadim ^a   Katritch, Vsevolod ^a   Wang, Ming Wei ^b   Stevens, Raymond C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c AMSTERDAM INSTITUTE FOR MOLECULES   (Netherlands)

^d SLAC NATIONAL ACCELERATOR LABORATORY   (United States)

^e NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLUCAGON; GLUCAGON RECEPTOR; LIGAND; PEPTIDE;

GLUCOSE; LIGAND; MEMBRANE; PROTEIN;

ALPHA HELIX; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; HYBRID; LIGAND BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; BINDING SITES; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; GLUCAGON; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CXCR4; RECEPTORS, GLUCAGON;

EID: 84881193006     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12393     Document Type: Article

References (44)

1. Lagerström, M. C. & Schioth, H.B. Structural diversity of Gprotein-coupled receptors and significance for drug discovery. Nature Rev. Drug Discov. 7, 339-357 (2008).
2. Cho, Y. M., Merchant, C. E. & Kieffer, T. J. Targeting the glucagon receptor family for diabetes and obesity therapy. Pharmacol. Ther. 135, 247-278 (2012).
3. Katritch, V., Cherezov, V. & Stevens, R. C. Structure-function of the G protein-coupledreceptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531-556 (2013).
4. Hoare, S. R. Mechanisms of peptide and nonpeptide ligand binding to class B G-protein-coupled receptors. Drug Discov. Today 10, 417-427 (2005). (Pubitemid 40450272)
5. Pal, K., Melcher, K. & Xu, H. E. Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta Pharmacol. Sin. 33, 300-311 (2012).
6. Koth, C. M. et al. Molecular basis for negative regulation of the glucagon receptor. Proc. Natl Acad. Sci. USA 109, 14393-14398 (2012).
7. Parthier, C., Reedtz-Runge, S., Rudolph, R. & Stubbs, M. T. Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem. Sci. 34, 303-310 (2009).
8. Underwood, C. R. et al. Crystal structure of glucagon-like peptide-1incomplex with the extracellular domain of the glucagon-like peptide-1 receptor. J. Biol. Chem. 285, 723-730 (2010).
9. Yaqub, T. et al. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. Mol. Pharmacol. 77, 547-558 (2010).
10. Miller, L. J., Dong, M., Harikumar, K. G. & Gao, F. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor. Biochem. Soc. Trans. 35, 709-712 (2007). (Pubitemid 47310350)
11. Dong, M. et al. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping. FASEB J. 26, 5092-5105 (2012).
12. Miller, L. J. et al. Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling. J. Biol. Chem. 286, 15895-15907 (2011).
13. Dong, M. et al. Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore. J. Biol. Chem. 286, 23888-23899 (2011).
14. Gensure, R. C., Shimizu, N., Tsang, J. & Gardella, T. J. Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor. Mol. Endocrinol. 17, 2647-2658 (2003). (Pubitemid 37542225)
15. de Graaf, C., Rein, C., Piwnica, D., Giordanetto, F. & Rognan, D. Structure-based discovery of allosteric modulators of two related class B G-protein-coupled receptors. ChemMedChem 6, 2159-2169 (2011).
16. Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967-976 (2012).
17. Ballesteros, J.A.& Weinstein, H. in Methods in Neurosciences Vol.25(ed. Sealfon, S. C.) 366-428 (Academic Press, 1995).
18. Wootten, D., Simms, J., Miller, L. J., Christopoulos, A. & Sexton, P. M. Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc. Natl Acad. Sci. USA 110, 5211-5216 (2013).
19. Unson, C. G. et al. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling. Biochemistry 41, 11795-11803 (2002).
20. Xiao, Q., Jeng, W. & Wheeler, M. B. Characterization of glucagon-like peptide-1 receptor-binding determinants. J. Mol. Endocrinol. 25, 321-335 (2000). (Pubitemid 32059305)
21. Roberts, D. J., Vertongen, P. & Waelbroeck, M. Analysis of the glucagon receptor first extracellular loop by the substituted cysteine accessibility method. Peptides 32, 1593-1599 (2011).
22. Wu, H. et al. Structure of the human k-opioid receptor in complex with JDTic. Nature 485, 327-332 (2012).
23. Manglik, A. et al. Crystal structure of the m-opioid receptor bound to a morphinan antagonist. Nature 485, 321-326 (2012).
24. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G. & Schioth, H. B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272 (2003). (Pubitemid 36627220)
25. Venkatakrishnan, A. J. et al. Molecular signatures of G-protein-coupled receptors. Nature 494, 185-194 (2013).
26. Inooka, H. et al. Conformation of a peptide ligand bound to its G-protein coupled receptor. Nature Struct. Biol. 8, 161-165 (2001). (Pubitemid 32116070)
27. Prévost, M. et al. Mutational and cysteine scanning analysis of the glucagon receptor N-terminal domain. J. Biol. Chem. 285, 30951-30958 (2010).
28. Ahn, J. M., Medeiros, M., Trivedi, D. & Hruby, V. J. Development of potent truncated glucagon antagonists. J. Med. Chem. 44, 1372-1379 (2001). (Pubitemid 32852113)
29. Coopman, K. et al. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor. Mol. Endocrinol. 25, 1804-1818 (2011).
30. Di Paolo, E. et al. Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Lett. 424, 207-210 (1998). (Pubitemid 28135315)
31. Perret, J. et al. Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue. Biochem. J. 362, 389-394 (2002). (Pubitemid 34214481)
32. Runge, S. et al. Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus. J. Biol. Chem. 278, 28005-28010 (2003). (Pubitemid 36899996)
33. Neumann, J. M. et al. Class-B GPCR activation: is ligand helix-capping the key? Trends Biochem. Sci. 33, 314-319 (2008).
34. Cascieri, M. A. et al. Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor. J. Biol. Chem. 274, 8694-8697 (1999). (Pubitemid 29164665)
35. Di Paolo, E. et al. Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. Receptors Channels 6, 309-315 (1999). (Pubitemid 29329025)
36. Koole, C. et al. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. J. Biol. Chem. 287, 3642-3658 (2012).
37. Tseng, C. C. & Lin, L. A point mutation in the glucose-dependent insulinotropic peptide receptor confers constitutive activity. Biochem. Biophys. Res. Commun. 232, 96-100 (1997). (Pubitemid 27211927)
38. Ganguli, S. C. et al. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J. Pharmacol. Exp. Ther. 286, 593-598 (1998). (Pubitemid 29003443)
39. Solano, R. M. et al. Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J. Biol. Chem. 276, 1084-1088 (2001). (Pubitemid 32098012)
40. Ceraudo, E. et al. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction. FASEB J. 26, 2060-2071 (2012).
41. Tan, Y. V., Couvineau, A. & Laburthe, M. Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP. J. Biol. Chem. 279, 38889-38894 (2004). (Pubitemid 39296049)
42. Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706-731 (2009).
43. DiPaolo, E. et al. Role of charged amino acids conservedin the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality. Peptides 20, 1187-1193 (1999).
44. Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370-D376 (2012).